Display options
Cite
Moghissi K. Endoscopic photodynamic therapy (PDT) for oesophageal cancer. Photodiagnosis Photodyn Ther. 2006;3(2):93-5doi: 10.1016/j.pdpdt.2006.03.005.
Moghissi, K. (2006). Endoscopic photodynamic therapy (PDT) for oesophageal cancer. Photodiagnosis and photodynamic therapy, 3(2), 93-5. https://doi.org/10.1016/j.pdpdt.2006.03.005
Moghissi, Keyvan. "Endoscopic photodynamic therapy (PDT) for oesophageal cancer." Photodiagnosis and photodynamic therapy vol. 3,2 (2006): 93-5. doi: https://doi.org/10.1016/j.pdpdt.2006.03.005
Moghissi K. Endoscopic photodynamic therapy (PDT) for oesophageal cancer. Photodiagnosis Photodyn Ther. 2006 Jun;3(2):93-5. doi: 10.1016/j.pdpdt.2006.03.005. Epub 2006 May 02. PMID: 25049097.
Copy Download .nbib Format: NLM
Share it on

Photodiagnosis Photodyn Ther. 2006 Jun;3(2):93-5. doi: 10.1016/j.pdpdt.2006.03.005. Epub 2006 May 02.

Endoscopic photodynamic therapy (PDT) for oesophageal cancer.

Photodiagnosis and photodynamic therapy

Keyvan Moghissi

Affiliations

  1. The Yorkshire Laser Centre, Goole & District Hospital, Woodland Avenue, Goole, East Yorkshire DN14 6RX, UK.

PMID: 25049097 DOI: 10.1016/j.pdpdt.2006.03.005

Abstract

Endoscopic photodynamic therapy (PDT) is undertaken only when tumour is visible endoscopically with malignancy biopsy confirmed. Patients will be either Group A: inoperable cases with locally advanced cancer when the aim is palliation of dysphagia, or Group E: patients with early stage I-II disease who are unsuitable for surgery or decline operation, when the intent is curative. Following assessment for suitability for PDT and counselling, Photofrin 2mg/(kgbw) is administered 24-72h before endoscopic illumination using a Diode 630nm laser. Illumination may be either interstitial or intraluminal at a dose of 100-200J/cm.

Publication Types